1. 1996 : 393-397 .
, . Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics . New York, NY: John Wiley and Sons, Inc;2. 1994 : 91-92 .
. Herbal Drugs and Phytopharmaceuticals . Boca Raton, Florida: CRC Press;3. 1999 : 1291-1330 .
. The Pharmacology of Chinese Herbs , 2nd ed. Boca Raton, Florida: CRC Press;4. Orange. In: The Encyclopedia Americana International Edition . Danbury, CT: Grolier Incorporated; 1989 : 9-11 .
5. 1996 : 188-189 .
. The Encyclopedia of Medicinal Plants . New York, NY: DK Publishing;6. Safety and efficacy of Citrus aurantium for weight loss . Am J Cardiol . 2004 ; ( 10 ): 1359-1361 . PubMed
, , .7. Bitter orange peel and synephrine . HerbalGram . 2005 ; . http://content.herbalgram.org/wholefoodsmarket/herbalgram/articleview.asp?a=2833 . Accessed November 9, 2007.
8. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement . Ann Pharmacother . 2004 ; ( 5 ): 812-816 . PubMed
, , .9. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol Pharm Bull . 2002 ; ( 12 ): 1629-1633 . PubMed
, .10. National Toxicology Program. Bitter orange ( Citrus aurantium var. amara) extracts and constituents (+/−) p-synephrine [CAS No. 94-07-5] and (+/−) p-octopamine [CAS No. 104-14-3] . Review of the Toxicological Literature . 2004 : 1-73 .
11. Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection . Anal Chim Acta . 2007 ; ( 1 ): 98-102 . PubMed
, , , .12. Pharmacological properties of citrus and their ancient and medieval uses in the Mediterranean region . J Ethnopharmacol . 2005 ; ( 1 ): 89-95 . PubMed
, .13. Neodiosmin, a flavone glycoside of Citrus aurantium . Phytochemistry . 1992 ; : 723-724 .
, , , .14. Standardization of the sour orange flower and leaf [in French] . Ann Pharm Fr . 1999 ; ( 5 ): 410-414 . PubMed
, , , .15. Studies on chemical constituents from the flower of Citrus aurantium [in Chinese] . Zhong Yao Cai . 2001 ; ( 12 ): 865-867 .
, , , .16. High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara . Phytochem Anal . 2004 ; ( 4 ): 220-225 . PubMed
, , .17. Synephrine. In: Buckingham J, exec ed. Dictionary of Natural Products, Vol 5: R-Z . New York: Chapman and Hall; 1994 : 5307-5308 .
18. Limonoid glucosides in Citrus aurantium . Phytochemistry . 1991 ; : 3803-3805 .
, , , .19. Isolimonic acid, a new citrus limonoid . Phytochemistry . 1980 ; : 2417-2419 .
, .20. New components of Citrus aurantium . Tetrahedron . 1960 ; : 64-66 .
, .21. Coumarin glycosides from Citrus flavedo . Phytochemistry . 1987 ; : 2547-2549 .
, , .22. Citrus aurantium , an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research . Exp Biol Med . 2004 ; : 698-704 . PubMed
, .23. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update . Obesity Rev . 2006 ; ( 1 ): 79-88. PubMed
, , , , , .24. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? Int J Obes . 2005 ; ( 4 ): 443-446 .
, , , , .25. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report . Fitoterapia . 1999 ; : 586-592 .
, , , et al.26. Obesity and medicinal plants . Fitoterapia . 2000 ; ( suppl 1 ):S73-S82. PubMed
, .27. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview . J Med . 2002 ; ( 1-4 ): 247-264 . PubMed
, , , .28. Effects of Citrus aurantium extract, caffeine, and St. John's Wort on body fat loss, lipid levels, and mood states in overweight healthy adults . Curr Ther Res Clin Exp . 1999 ; : 145-153 .
, , , , .29. Blood pressure and heart rate effects following a single dose of bitter orange . Ann Pharmacother . 2006 ; ( 1 ): 53-57 . PubMed
, , .30. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults . J Clin Pharmacol . 2001 ; ( 10 ): 1059-1063 . PubMed
, , , , , .31. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects . Pharmacotherapy . 2005 ; ( 12 ): 1719-1724 . PubMed
, , , .32. Synephrine pharmacokinetics and cardiovascular changes after ingestion of Citrus aurantium dietary supplements . Clin Pharmacol Ther . 2005 ; : P5 .
, , , .33. Hemodynamic effects of ephedra-free weight-loss supplements in humans . Am J Med . 2005 ; ( 9 ): 998-1003 . PubMed
, , .34. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males . Int J Obes . 2006 ; ( 5 ): 764-773 .
, , .35. Antidepressant-like effects of p-synephrine in mouse models of immobility tests . Neurosci Lett . 1996 ; ( 2-3 ): 107-110 . PubMed
, , , , , .36. Characterization of antidepressant-like effects of p-synephrine stereoisomers . Naunyn Schmiedebergs Arch Pharmacol . 2001 ; ( 1 ): 21-26 .
, , , et al.37. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics . J Clin Pharmacol . 2002 ; ( 10 ): 1165-1170 . PubMed
, , , et al.38. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins . Clin Pharmacol Ther . 2001 ; ( 1 ): 14-23 .
, , , .39. The effect of grapefruit juice and Seville orange juice on the pharmacokinetics of dextromethrophan: the role of gut CYP3A and P-glycoprotein . Life Sci . 2002 ; ( 10 ): 1149-1160 . PubMed
, , , .40. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine . Mayo Clin Proc . 2005 ; ( 4 ): 541-545 . PubMed
, , , , .41. Adverse reaction to an adrenergic herbal extract ( Citrus aurantium ) . Phytomedicine . 2005 ; ( 3 ): 247-248 . PubMed
, , .42. Variant angina associated with bitter orange in a dietary supplement . Mayo Clinic Proc . 2006 ; ( 4 ): 545-548 . PubMed
, , , , .43. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement . Mil Med . 2007 ; ( 6 ): 656-658 .
, , , .44. Suppressive effect of Citrus aurantium against body fat accumulation and its safety . J Clin Biochem Nutr . 2005 ; ( 1 ): 11-17 .
, , , .45. The effects of Citrus aurantium and its active ingredient N-methyltyramine on the cardiovascular receptors . Yao Xue Xue Bao . 1981 ; ( 4 ): 253-259 . PubMed
, , , , .46. Hemodynamic effects of synephrine treatment in portal hypertensive rats . Jpn J Pharmacol . 2001 ; ( 2 ): 183-188 . PubMed
, , , , , .47. Consumption of dietary supplements containing Citrus aurantium (bitter orange)—2004 California Behavioral Risk Factor Surveillance Survey (BRFSS) . Ann Pharmacother . 2006 ; ( 10 ): 1747-1751 . PubMed
, , .48. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . Hypertension . 2003 ; ( 6 ): 1206-1252 . PubMed
, , , et al; .49. Response of CEDIA amphetamines assay after a single dose of bitter orange . Ther Drug Monit . 2006 ; ( 2 ): 252-254 . PubMed
, , .